Our exclusive report on the human liver models market provides comprehensive insights about the current market scenario, successful business strategies adopted by vendors, growth estimates, the impact of the pandemic, and customer behavior.
Download a Free Sample Now to understand the scope of the full report.
The market is driven by the increasing prevalence of liver diseases. Liver diseases such as liver cancer is one of the leading causes of death globally. The prevalence of the condition is increasing with the rising incidence of risk factors such as hepatitis B and C and underlying cirrhosis. Also, the increasing incidence of lifestyle-associated risk factors such as diabetes, obesity, and fatty liver disease has been increasing the prevalence of liver cancer globally. The high prevalence of such diseases is attracting significant funding in the R&D for the causative factors to reduce the incidence of liver cancer. This will have a positive impact on the growth of the human liver models during the forecast period.
Also, technological advancements in the human organ model, an increase in collaborations for liver cancer drug development, and robust R&D activities will foster the growth of the market through 2026.
The human liver models market covers the following areas:
The human liver models market analysis includes the type segment and geographic landscape. By type, the liver organoids is expected to offer significant growth opportunities for market players. The segment is driven by the increasing need for diagnosis of liver disease coupled with the rising need for R&D and drug development. In addition, recent advances in three-dimensional cell culture technology will have a positive impact on the growth of the segment during the forecast period.
By geography, North America will have the largest share of the market. The region currently holds 35% of the global market share. Advances in research on drugs in clinical trial stages and surgeries will be crucial in driving the growth of the regional market. Also, the presence of an advanced healthcare system and the increasing number of patient assistance programs by various large pharmaceutical vendors will contribute to the growth of the human liver models market in North America during the forecast period.
Companies Mentioned
The human liver models market is fragmented with the presence of some global and local industry participants. Large vendors are acquiring and forming mergers with other vendors to increase their market share. Other prominent vendors also hold a significant position in the market. With the growing competition, vendors are trying to stay competitive and improve their profitability.
- BioIVT LLC
- CELLINK AB
- CN Bio Innovations Ltd.
- Corning Inc.
- Cyfuse Biomedical K.K.
- Emulate Inc.
- H. L. Scientific
- Hangzhou Jienuofei Biotechnology Co. Ltd.
- InSphero AG
- Kirkstall Ltd.
Download a Free Sample for highlights on other dominating players and high revenue-generating segments in the market.
Related Reports:
Humanized Mouse Model Market by Product, End-user, and Geography - Forecast and Analysis 2021-2025
Blood Pressure Monitoring Device Market by Product and Geography Forecast and Analysis 2022-2026
Human Liver Models Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Decelerate at a CAGR of 12.94% |
Market growth 2022-2026 |
USD 1.91 billion |
Market structure |
Fragmented |
YoY growth (%) |
16.76 |
Regional analysis |
North America, Europe, APAC, Middle East and Africa, and South America |
Performing market contribution |
North America at 35% |
Key consumer countries |
US, China, Japan, Germany, and UK |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
BioIVT LLC, CELLINK AB, CN Bio Innovations Ltd., Corning Inc., Cyfuse Biomedical K.K., Emulate Inc., H. L. Scientific, Hangzhou Jienuofei Biotechnology Co. Ltd., InSphero AG, Kirkstall Ltd., LifeSpan BioSciences Inc., MIMETAS BV, N. C. KANSIL and SONS, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and Western Surgical |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Key Topics Covered:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Liver organoids - Market size and forecast 2021-2026
- Exhibit 28: Chart on Liver organoids - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Liver organoids - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Liver organoids - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Liver organoids - Year-over-year growth 2021-2026 (%)
- 5.4 Liver-on-a-chip - Market size and forecast 2021-2026
- Exhibit 32: Chart on Liver-on-a-chip - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Liver-on-a-chip - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Liver-on-a-chip - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Liver-on-a-chip - Year-over-year growth 2021-2026 (%)
- 5.5 2D models - Market size and forecast 2021-2026
- Exhibit 36: Chart on 2D models - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on 2D models - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on 2D models - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on 2D models - Year-over-year growth 2021-2026 (%)
- 5.6 3D bioprinting - Market size and forecast 2021-2026
- Exhibit 40: Chart on 3D bioprinting - Market size and forecast 2021-2026 ($ million)
- Exhibit 41: Data Table on 3D bioprinting - Market size and forecast 2021-2026 ($ million)
- Exhibit 42: Chart on 3D bioprinting - Year-over-year growth 2021-2026 (%)
- Exhibit 43: Data Table on 3D bioprinting - Year-over-year growth 2021-2026 (%)
- 5.7 Market opportunity by Type
- Exhibit 44: Market opportunity by Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 46: Chart on Market share by geography 2021-2026 (%)
- Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 48: Chart on Geographic comparison
- Exhibit 49: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 APAC - Market size and forecast 2021-2026
- Exhibit 58: Chart on APAC - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on APAC - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on APAC - Year-over-year growth 2021-2026 (%)
- 7.6 Middle East and Africa - Market size and forecast 2021-2026
- Exhibit 62: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
- 7.7 South America - Market size and forecast 2021-2026
- Exhibit 66: Chart on South America - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on South America - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on South America - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on South America - Year-over-year growth 2021-2026 (%)
- 7.8 US - Market size and forecast 2021-2026
- Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.9 Germany - Market size and forecast 2021-2026
- Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.10 UK - Market size and forecast 2021-2026
- Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.11 China - Market size and forecast 2021-2026
- Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.12 Japan - Market size and forecast 2021-2026
- Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.13 Market opportunity by geography
- Exhibit 90: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 91: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 93: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 94: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 95: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 96: Matrix on vendor position and classification
- 10.3 BioIVT LLC
- Exhibit 97: BioIVT LLC - Overview
- Exhibit 98: BioIVT LLC - Product / Service
- Exhibit 99: BioIVT LLC - Key news
- Exhibit 100: BioIVT LLC - Key offerings
- 10.4 CELLINK AB
- Exhibit 101: CELLINK AB - Overview
- Exhibit 102: CELLINK AB - Business segments
- Exhibit 103: CELLINK AB - Key offerings
- Exhibit 104: CELLINK AB - Segment focus
- 10.5 CN Bio Innovations Ltd.
- Exhibit 105: CN Bio Innovations Ltd. - Overview
- Exhibit 106: CN Bio Innovations Ltd. - Product / Service
- Exhibit 107: CN Bio Innovations Ltd. - Key offerings
- 10.6 Corning Inc.
- Exhibit 108: Corning Inc. - Overview
- Exhibit 109: Corning Inc. - Business segments
- Exhibit 110: Corning Inc. - Key offerings
- Exhibit 111: Corning Inc. - Segment focus
- 10.7 Cyfuse Biomedical K.K.
- Exhibit 112: Cyfuse Biomedical K.K. - Overview
- Exhibit 113: Cyfuse Biomedical K.K. - Product / Service
- Exhibit 114: Cyfuse Biomedical K.K. - Key offerings
- 10.8 Emulate Inc.
- Exhibit 115: Emulate Inc. - Overview
- Exhibit 116: Emulate Inc. - Product / Service
- Exhibit 117: Emulate Inc. - Key offerings
- 10.9 Hangzhou Jienuofei Biotechnology Co. Ltd.
- Exhibit 118: Hangzhou Jienuofei Biotechnology Co. Ltd. - Overview
- Exhibit 119: Hangzhou Jienuofei Biotechnology Co. Ltd. - Product / Service
- Exhibit 120: Hangzhou Jienuofei Biotechnology Co. Ltd. - Key offerings
- 10.10 InSphero AG
- Exhibit 121: InSphero AG - Overview
- Exhibit 122: InSphero AG - Product / Service
- Exhibit 123: InSphero AG - Key news
- Exhibit 124: InSphero AG - Key offerings
- 10.11 MIMETAS BV
- Exhibit 125: MIMETAS BV - Overview
- Exhibit 126: MIMETAS BV - Product / Service
- Exhibit 127: MIMETAS BV - Key offerings
- 10.12 Organovo Holdings Inc.
- Exhibit 128: Organovo Holdings Inc. - Overview
- Exhibit 129: Organovo Holdings Inc. - Business segments
- Exhibit 130: Organovo Holdings Inc. - Key offerings
- Exhibit 131: Organovo Holdings Inc. - Segment focus
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 132: Inclusions checklist
- Exhibit 133: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 134: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 135: Research methodology
- Exhibit 136: Validation techniques employed for market sizing
- Exhibit 137: Information sources
- 11.5 List of abbreviations
- Exhibit 138: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article